mortality/aging
• those that survive to birth die postnatally due to lethal vascular defects in 30% and severe craniofacial defects in 100% of mutants
|
• 25% die prior to birth
|
cardiovascular system
• 30% show lethal vascular defects, however outflow tract development is normal
|
• 95% have abnormal fourth pharyngeal arch artery formation at E10.5
• migration and early differentiation of the 4th pharyngeal arch artery endothelial cells occurs normally but subsequent vascular organization fails such that at the 35-37 somite stage, endothelial cells remain disorganized and fail to form primitive vascular tubes, long after this vessel is patent and pericyte recruitment is under way in controls
|
• 33% display bilateral aplasia of the fourth and sixth pharyngeal arch arteries at E10.5
|
• 12% show bilateral hypoplasia of the 4th pharyngeal arch arteries
|
• 33% display bilateral aplasia of the fourth and sixth pharyngeal arch arteries at E10.5
|
• exhibit an abnormally large third pharyngeal arch artery
|
• 30% of E18.5 mutants have interrupted aortic arch type B (IAAB)
|
• 13% exhibit circumflex right aortic arch (RAA) or RAA with right ductus arteriosus
|
• 46% exhibit coronary artery anomalies, in isolation or associated with other vascular defects
|
• subclavian artery anomalies
|
• 80% exhibit retroesophageal right subclavian artery or abnormal subclavian branching associated with other defects
|
craniofacial
• 100% show severe craniofacial malformations
|
• 95% have abnormal fourth pharyngeal arch artery formation at E10.5
• migration and early differentiation of the 4th pharyngeal arch artery endothelial cells occurs normally but subsequent vascular organization fails such that at the 35-37 somite stage, endothelial cells remain disorganized and fail to form primitive vascular tubes, long after this vessel is patent and pericyte recruitment is under way in controls
|
• 33% display bilateral aplasia of the fourth and sixth pharyngeal arch arteries at E10.5
|
• 12% show bilateral hypoplasia of the 4th pharyngeal arch arteries
|
• 33% display bilateral aplasia of the fourth and sixth pharyngeal arch arteries at E10.5
|
• exhibit an abnormally large third pharyngeal arch artery
|
• exhibit severe pharyngeal arch 1 hypoplasia and hypoplasia and fusion of the more caudal pharyngeal arches as early as E9.5
|
embryo
• 95% have abnormal fourth pharyngeal arch artery formation at E10.5
• migration and early differentiation of the 4th pharyngeal arch artery endothelial cells occurs normally but subsequent vascular organization fails such that at the 35-37 somite stage, endothelial cells remain disorganized and fail to form primitive vascular tubes, long after this vessel is patent and pericyte recruitment is under way in controls
|
• 33% display bilateral aplasia of the fourth and sixth pharyngeal arch arteries at E10.5
|
• 12% show bilateral hypoplasia of the 4th pharyngeal arch arteries
|
• 33% display bilateral aplasia of the fourth and sixth pharyngeal arch arteries at E10.5
|
• exhibit an abnormally large third pharyngeal arch artery
|
• exhibit an increase in apoptosis of neural crest cells migrating from rhombomeres 6-8
|
• exhibit severe pharyngeal arch 1 hypoplasia and hypoplasia and fusion of the more caudal pharyngeal arches as early as E9.5
|
cellular
• exhibit an increase in apoptosis of neural crest cells migrating from rhombomeres 6-8
|